tiprankstipranks
Trending News
More News >
biote (BTMD)
NASDAQ:BTMD
US Market
Advertisement

biote (BTMD) Earnings Dates, Call Summary & Reports

Compare
111 Followers

Earnings Data

Report Date
Mar 18, 2026
After Close (Not Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.06
Last Year’s EPS
0.1
Same Quarter Last Year
Based on 4 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Biote faced challenges with declining procedure revenue and adjusted EBITDA, largely due to the ongoing transformation of its commercial team and higher attrition rates. However, the company showed positive signs with growth in dietary supplements, improved gross profit margin, increased cash flow, and strategic share repurchases. The successful marketing event also reinforced its market leadership.
Company Guidance
During the Biote Third Quarter 2025 Earnings Conference Call, the company reiterated its fiscal 2025 revenue guidance of over $190 million and adjusted EBITDA guidance of over $50 million. The third quarter revenue was $48.0 million, marking a 6.7% decrease from the previous year. Procedure revenue declined by 10.4%, while dietary supplements revenue grew by 8.4%, driven mainly by e-commerce channel growth. The gross profit margin improved to 71.8%, reflecting cost savings from the vertical integration of their manufacturing facility. Adjusted EBITDA decreased by 20.5% to $12.9 million, with an adjusted EBITDA margin of 26.9%, down from 31.5% in the prior year, attributed to lower sales and higher operating expenses. The company highlighted that the transformation of its commercial team had impacted short-term procedure revenue but expressed confidence in returning to growth. Biote also repurchased approximately 1 million shares of its Class A common stock and amended settlement agreements, resulting in significant cash flow savings.
Dietary Supplements Revenue Growth
Dietary supplements revenue grew 8.4% to $11.2 million, primarily driven by the continued growth of the e-commerce channel. Biote expects mid-teens revenue growth for the dietary supplements business for the fiscal year 2025.
Gross Profit Margin Improvement
Gross profit margin increased by 150 basis points to 71.8%, reflecting cost savings from the vertical integration of the 503(B) manufacturing facility and effective cost management.
Increased Cash Flow from Operations
Third quarter cash flow from operations increased by $14.1 million to $27.6 million.
Share Repurchase Program
Biote repurchased approximately 1 million shares of Class A common stock at an average price of $3.28 per share under the $20 million common share repurchase program.
Successful Marketing Event
Biote hosted the annual Sun, Sea and Biote marketing event, attracting over 800 attendees and featuring notable speakers, reinforcing its leadership in hormone optimization.

biote (BTMD) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BTMD Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 18, 2026
2025 (Q4)
0.06 / -
0.1
Nov 05, 2025
2025 (Q3)
0.08 / 0.22
0.33-33.33% (-0.11)
Aug 06, 2025
2025 (Q2)
0.08 / 0.10
-0.19152.63% (+0.29)
May 07, 2025
2025 (Q1)
0.08 / 0.37
-0.06716.67% (+0.43)
Mar 12, 2025
2024 (Q4)
0.11 / 0.10
0.18-44.44% (-0.08)
Nov 12, 2024
2024 (Q3)
0.12 / 0.33
0.2437.50% (+0.09)
Aug 08, 2024
2024 (Q2)
0.09 / -0.19
-0.2524.00% (+0.06)
May 07, 2024
2024 (Q1)
0.05 / -0.06
-0.3984.62% (+0.33)
Mar 12, 2024
2023 (Q4)
0.08 / 0.18
0.180.00% (0.00)
Nov 07, 2023
2023 (Q3)
0.07 / 0.24
-1.74113.79% (+1.98)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

BTMD Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$2.93$2.84-3.07%
Aug 06, 2025
$3.86$2.92-24.35%
May 07, 2025
$3.34$3.74+11.98%
Mar 12, 2025
$4.10$3.07-25.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does biote (BTMD) report earnings?
biote (BTMD) is schdueled to report earning on Mar 18, 2026, After Close (Not Confirmed).
    What is biote (BTMD) earnings time?
    biote (BTMD) earnings time is at Mar 18, 2026, After Close (Not Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BTMD EPS forecast?
          BTMD EPS forecast for the fiscal quarter 2025 (Q4) is 0.06.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis